Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-06-08
1989-07-11
Siegel, Alan
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514444, 549 59, 549 60, 549 65, A61K 3138, C07D40900, C07D33332
Patent
active
048472891
ABSTRACT:
Aryl (or aralkyl)-sulfonylthiophene-2-sulfonamides containing a basic functional group as a substituent are efficacious in the treatment of elevated intraocular pressure and glaucoma following topical ocular administration.
REFERENCES:
patent: 4386098 (1983-05-01), Woltersdorf et al.
patent: 4416890 (1983-11-01), Woltersdorf et al.
patent: 4426388 (1984-01-01), Woltersdorf
patent: 4477466 (1984-10-01), Shepard
patent: 4486444 (1984-12-01), Shepard
patent: 4542152 (1985-09-01), Shepard
patent: 4585787 (1986-04-01), Shepard
patent: 4665090 (1987-05-01), Graham
patent: 4668697 (1987-05-01), Shepard et al.
patent: 4677115 (1987-06-01), Baldwin et al.
J. Med. Chem., 1981, 24, 959-964, Barnish et al.
Baldwin John J.
Graham Samuel L.
Habecker Charles M.
Halczenko Wasyl
Hartman George D.
Merck & Co. , Inc.
Nicholson William H.
Siegel Alan
Sudol, Jr. Michael C.
LandOfFree
Thiophene sulfonamide antiglaucoma agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiophene sulfonamide antiglaucoma agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiophene sulfonamide antiglaucoma agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-437584